Cardiovascular Disease Early Detection and Prevention Act of 2026

Congress finds the following:

(1) Cardiovascular disease is the leading cause of death in the United States.

(2) Routine cholesterol panels often fail to detect elevated Lipoprotein(a) (Lp(a)) and Apolipoprotein B (ApoB) levels.

(3) Approximately 1 in 5 Americans have elevated Lp(a) levels.

(4) Elevated ApoB levels predict cardiovascular risk better than LDL cholesterol alone.

(5) Nearly 50 percent of heart attack survivors die within five years without effective risk management.